Recap: Ligand Pharmaceuticals Q3 Earnings

Ligand Pharmaceuticals LGND reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Ligand Pharmaceuticals their estimated earnings by 51.92%, reporting an EPS of $1.58 versus an estimate of $1.04, which surprised analysts.

Revenue was up $22,987,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.29, which was followed by a 4.58% drop in the share price the next day.

Here's a look at Ligand Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.